Back
EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets.
Journal article

EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets.

  • Flores-Montero J Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain and; Centro de Investigación Biomédica en Red de Cáncer: CIBER-ONC (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
  • Grigore G Cytognos SL, Salamanca, Spain.
  • Fluxá R Cytognos SL, Salamanca, Spain.
  • Hernández J Cytognos SL, Salamanca, Spain.
  • Fernandez P FACS/Stem cell Laboratory, Institute of Laboratory Medicine, Kantonsspital Aarau AG, Aarau, Switzerland.
  • Almeida J Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain and; Centro de Investigación Biomédica en Red de Cáncer: CIBER-ONC (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
  • Muñoz N Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain and; Centro de Investigación Biomédica en Red de Cáncer: CIBER-ONC (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
  • Böttcher S Division of Internal Medicine, Medical Clinic III, Hematology, Oncology and Palliative Medicine, Special Hematology Laboratory, Rostock University Medical Center, Rostock, Germany.
  • Sedek L Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland.
  • van der Velden V Department of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Barrena S Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain and; Centro de Investigación Biomédica en Red de Cáncer: CIBER-ONC (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
  • Hernández A Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain and; Centro de Investigación Biomédica en Red de Cáncer: CIBER-ONC (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
  • Paiva B Clínica Universidad de Navarranica, CIMA, IDISNA, CIBERONC CB16/12/00369, Pamplona, Spain.
  • Lecrevisse Q Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain and; Centro de Investigación Biomédica en Red de Cáncer: CIBER-ONC (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
  • Lima M Department of Hematology, Laboratory of Cytometry, Hospital de Santo António, Centro Hospitalar do Porto, and Unit for Multidisciplinary Research in Biomedicine (UMIB), Porto, Portugal.
  • Santos AH Department of Hematology, Laboratory of Cytometry, Hospital de Santo António, Centro Hospitalar do Porto, and Unit for Multidisciplinary Research in Biomedicine (UMIB), Porto, Portugal.
  • van Dongen JJM Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: J.J.M.van_Dongen@lumc.nl.
  • Orfao A Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain and; Centro de Investigación Biomédica en Red de Cáncer: CIBER-ONC (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: orfao@usal.es.
Show more…
  • 2019-08-28
Published in:
  • Journal of immunological methods. - 2019
Algorithms
Databases as Topic
Flow Cytometry
Humans
Immunophenotyping
Lymphocyte Subsets
Lymphoproliferative Disorders
English In recent years the volume and complexity of flow cytometry data has increased substantially. This has led to a greater number of identifiable cell populations in a single measurement. Consequently, new gating strategies and new approaches for cell population definition are required. Here we describe how the EuroFlow Lymphoid Screening Tube (LST) reference data base for peripheral blood (PB) samples was designed, constructed and validated for automated gating of the distinct lymphoid (and myeloid) subsets in PB of patients with chronic lymphoproliferative disorders (CLPD). A total of 46 healthy/reactive PB samples which fulfilled pre-defined technical requirements, were used to construct the LST-PB reference data base. In addition, another set of 92 PB samples (corresponding to 10 healthy subjects, 51 B-cell CLPD and 31 T/NK-cell CLPD patients), were used to validate the automated gating and cell-population labeling tools with the Infinicyt software. An overall high performance of the LST-PB data base was observed with a median percentage of alarmed cellular events of 0.8% in 10 healthy donor samples and of 44.4% in CLPD data files containing 49.8% (range: 1.3-96%) tumor cells. The higher percent of alarmed cellular events in every CLPD sample was due to aberrant phenotypes (75.6% cases) and/or to abnormally increased cell counts (86.6% samples). All 18 (22%) data files that only displayed numerical alterations, corresponded to T/NK-cell CLPD cases which showed a lower incidence of aberrant phenotypes (41%) vs B-cell CLPD cases (100%). Comparison between automated vs expert-bases manual classification of normal (r2 = 0.96) and tumor cell populations (rho = 0.99) showed a high degree of correlation. In summary, our results show that automated gating of cell populations based on the EuroFlow LST-PB data base provides an innovative, reliable and reproducible tool for fast and simplified identification of normal vs pathological B and T/NK lymphocytes in PB of CLPD patients.
Language
  • English
Open access status
hybrid
Identifiers
Persistent URL
https://sonar.ch/global/documents/212730
Statistics
Document views: 31 File downloads: